Cosmo to Host Investor Day on April 9, 2025
Cosmo Pharmaceuticals has announced it will host an Investor Day on Wednesday, April 9, 2025, at the Park Hyatt Hotel in Zurich, Switzerland. The event will commence at 11:00am CET, featuring presentations followed by lunch.
The program will include detailed presentations from the Management team covering the company's R&D pipeline, long-term strategic initiatives, and growth opportunities. CEO Giovanni Di Napoli and the executive team will conduct a Q&A session with investors, analysts, and media representatives.
Registration details for in-person attendance and live webcast information will be available in the Events & Presentations section of Cosmo's website. A replay of the webcast will be provided after the event.
Cosmo Pharmaceuticals ha annunciato che ospiterà un Investor Day mercoledì 9 aprile 2025, presso l'Hotel Park Hyatt a Zurigo, Svizzera. L'evento avrà inizio alle 11:00 CET, con presentazioni seguite da un pranzo.
Il programma includerà presentazioni dettagliate da parte del team di gestione che tratteranno il pipeline R&D dell'azienda, iniziative strategiche a lungo termine e opportunità di crescita. Il CEO Giovanni Di Napoli e il team esecutivo condurranno una sessione di domande e risposte con investitori, analisti e rappresentanti dei media.
Le informazioni per la registrazione per la partecipazione di persona e per la diretta web saranno disponibili nella sezione Eventi e Presentazioni del sito web di Cosmo. Una registrazione della diretta sarà fornita dopo l'evento.
Cosmo Pharmaceuticals ha anunciado que organizará un Día del Inversor el miércoles 9 de abril de 2025, en el Hotel Park Hyatt en Zúrich, Suiza. El evento comenzará a las 11:00 a.m. CET, con presentaciones seguidas de un almuerzo.
El programa incluirá presentaciones detalladas del equipo de gestión que cubrirán el pipeline de I+D de la empresa, iniciativas estratégicas a largo plazo y oportunidades de crecimiento. El CEO Giovanni Di Napoli y el equipo ejecutivo llevarán a cabo una sesión de preguntas y respuestas con inversores, analistas y representantes de los medios.
Los detalles de registro para la asistencia en persona y la información sobre la transmisión en vivo estarán disponibles en la sección de Eventos y Presentaciones del sitio web de Cosmo. Se proporcionará una repetición de la transmisión después del evento.
Cosmo Pharmaceuticals는 2025년 4월 9일 수요일 스위스 취리히의 파크 하얏트 호텔에서 투자자 데이를 개최한다고 발표했습니다. 이 행사는 CET 기준 오전 11시에 시작되며, 프레젠테이션 후 점심이 제공됩니다.
프로그램에는 회사의 R&D 파이프라인, 장기 전략적 이니셔티브 및 성장 기회를 다루는 경영진의 상세한 프레젠테이션이 포함됩니다. CEO 조반니 디 나폴리와 경영진 팀은 투자자, 분석가 및 언론 대표들과의 질의응답 세션을 진행할 것입니다.
현장 참석 및 라이브 웹캐스트 정보에 대한 등록 세부사항은 Cosmo 웹사이트의 이벤트 및 프레젠테이션 섹션에서 확인할 수 있습니다. 이벤트 후 웹캐스트의 재생이 제공될 것입니다.
Cosmo Pharmaceuticals a annoncé qu'elle organisera un Investor Day le mercredi 9 avril 2025, à l'hôtel Park Hyatt à Zurich, en Suisse. L'événement commencera à 11h00 CET, avec des présentations suivies d'un déjeuner.
Le programme comprendra des présentations détaillées de l'équipe de direction portant sur le pipeline R&D de l'entreprise, des initiatives stratégiques à long terme et des opportunités de croissance. Le PDG Giovanni Di Napoli et l'équipe exécutive animeront une session de questions-réponses avec des investisseurs, des analystes et des représentants des médias.
Les détails d'inscription pour la participation en personne et les informations sur la diffusion en direct seront disponibles dans la section Événements et Présentations du site Web de Cosmo. Un replay du webinaire sera fourni après l'événement.
Cosmo Pharmaceuticals hat angekündigt, am Mittwoch, den 9. April 2025, einen Investor Day im Park Hyatt Hotel in Zürich, Schweiz, auszurichten. Die Veranstaltung beginnt um 11:00 Uhr CET und umfasst Präsentationen, gefolgt von einem Mittagessen.
Das Programm beinhaltet detaillierte Präsentationen des Management-Teams, die sich mit der F&E-Pipeline des Unternehmens, langfristigen strategischen Initiativen und Wachstumschancen befassen. CEO Giovanni Di Napoli und das Führungsteam werden eine Frage-und-Antwort-Runde mit Investoren, Analysten und Medienvertretern leiten.
Registrierungsdetails für die persönliche Teilnahme und Informationen zur Live-Webcast sind im Bereich Veranstaltungen & Präsentationen auf der Website von Cosmo verfügbar. Eine Wiederholung des Webcasts wird nach der Veranstaltung bereitgestellt.
- None.
- None.
Dublin, Ireland--(Newsfile Corp. - February 12, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce that it will host an Investor Day on Wednesday, April 9, 2025.
The live event will be held at the Hotel “Park Hyatt” at Beethovenstrasse 21 in 8002 Zurich, Switzerland. The presentation will begin at 11:00am CET and will be followed by lunch.
Cosmo’s Investor Day event will include presentations from the Management team on Cosmo’s R&D pipeline, long-term strategic initiatives and growth opportunities. CEO Giovanni Di Napoli and the executive team are looking forward to the subsequent Q&A session with investors, analysts and media representatives.
The link with registration details (for those attending in person) along with the live webcast details (for those joining online) will be made available under the Events & Presentations section of Cosmo’s website. A replay of the webcast will be available after the event.
About Cosmo
Cosmo Pharmaceuticals N.V. is committed to revolutionizing healthcare and transforming people’s lives by researching and developing innovative products that tackle unfulfilled healthcare demands. As a pharmaceutical company, Cosmo is active in the areas of Healthtech/AI, dermatology, gastroenterology and contract manufacturing & development. For the commercialization and distribution of its products, Cosmo collaborates with leading partners worldwide, including Medtronic and Sun Pharma. Founded in 1997, Cosmo is headquartered in Dublin (Ireland) and has offices also in San Diego (USA), and Lainate/Rome/Catania (Italy). The Company had approximately 330 employees at the end of 2024, all dedicated to making a significant impact in the field of healthcare. For more information, please visit www.cosmopharma.com.
Upcoming Events
| 2024 Full-Year Results (unaudited) | March 6, 2025 |
| J.P. Morgan European Opportunities Forum, London | March 12, 2025 |
| 2024 Annual Report Publication | March 20, 2025 |
| 26th Kepler Cheuvreux Swiss Seminar, Zurich | March 20, 2025 |
| Life Sciences Conference, Amsterdam | April 2-3, 2025 |
| Investor Day 2025 | April 9, 2025 |
| 2025 Half-Year Results and Report | July 23, 2025 |
For information requests about Cosmo’s Investor Day 2025, please contact:
Hazel Winchester, Head of Investor Relations
Cosmo Pharmaceuticals N.V.
Tel: +353 1 817 03 70
hwinchester@cosmopharma.com
Attachments
250212_Cosmo_Announcement_Investor Day 2025_english_final
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240533
FAQ
When and where is Cosmo Pharmaceuticals' 2025 Investor Day?
What topics will be covered at Cosmo's 2025 Investor Day?
How can investors participate in Cosmo's 2025 Investor Day?
Will there be a Q&A session at Cosmo's 2025 Investor Day?
Will Cosmo's 2025 Investor Day presentation be available after the event?
